Heron Therapeutics Inc (HRTX) has gained Wednesday morning, with the stock gaining 0.76% in pre-market trading to 1.32. HRTX's short-term technical score of 39 indicates that the stock has traded less bullishly over the last month than 61% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, Heron Therapeutics Inc ranks higher than 58% of stocks. Heron Therapeutics Inc has risen 114.75% over the past month, closing at $0.68 on October 25. During this period of time, the stock fell as low as $0.54 and as high as $1.39. HRTX has an average analyst recommendation of Strong Buy. The company has an average price target of $5.63.
HRTX has an Overall Score of 61. Find out what this means to you and get the rest of the rankings on HRTX!